Hayne, Dickon <br/><br/>
BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned.  [electronic resource] 

 -  BJU international  05 2017 
 - 55-57 p.  digital 
<br/><br/> Publication Type: Letter; Meta-Analysis; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1464-410X 
<br/><br/><label>Standard No.: </label>10.1111/bju.13873  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravesical<br/>Australia<br/>BCG Vaccine--administration & dosage<br/>Clinical Trials, Phase III as Topic<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Male<br/>Mitomycin--administration & dosage<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Staging<br/>Prognosis<br/>Randomized Controlled Trials as Topic<br/>Risk Assessment<br/>Survival Analysis<br/>Treatment Outcome<br/>Urinary Bladder Neoplasms--drug therapy